A detailed history of Pathstone Holdings, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 17,603 shares of DXCM stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,603
Previous 27,840 36.77%
Holding current value
$1.33 Million
Previous $3.16 Million 62.64%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$64.0 - $116.06 $655,168 - $1.19 Million
-10,237 Reduced 36.77%
17,603 $1.18 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $191,277 - $243,540
1,734 Added 6.64%
27,840 $3.16 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $24,785 - $30,401
217 Added 0.84%
26,106 $3.62 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $1.95 Million - $3.21 Million
25,889 New
25,889 $3.21 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.